InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Malley Thomas, Director. Director active across 5 companies, notably BeiGene, Ltd.. In total, 10 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €525k. Activity tracked since 16 June 2021. The latest transaction was filed on 18 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Malley Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
10,000 shares@ US$3.124.9% of flowCommon StockSEC:0001193125-26-116834:0
21,959 shares@ US$1.86100.0% of flowClass A Ordinary SharesSEC:0001415889-25-021941:0
3,173 sharesClass A Ordinary SharesSEC:0001415889-25-015796:0
4,373 sharesClass A Common SharesSEC:0001415889-24-016002:0
5,000 sharesClass A Common SharesSEC:0001415889-23-010564:0
50,000 shares@ US$11.50100.0% of flowCommon stockSEC:0001209191-23-038797:0
Canonical exit: 14 Sept 2023 (T+90)
12,922 shares0Ordinary SharesSEC:0001651308-23-000097:0
16,692 shares0Ordinary SharesSEC:0001651308-22-000104:0
7,800 shares0Ordinary SharesSEC:0001651308-21-000121:0
1,356 sharesCommon StockSEC:0001179110-16-017273:0
10 of 10 declarations
About Malley Thomas
Malley Thomas is Administrateur and has 10 filings in total. In the sampled recent filings, they cover the period from 2016-01-05 to 2026-03-20, with transactions mainly consisting of option exercises, and a buy volume of EUR 525309 versus EUR 0 in sales. They are listed as a director of BeiGene, Ltd., Kura Oncology, Inc., Kiniksa Pharmaceuticals International, plc, Kiniksa Pharmaceuticals, Ltd., and OvaScience, Inc.
